Large-scale testing (Phase 3)Study completedNCT01979952
What this trial is testing
Nintedanib Twice Daily vs Placebo in Patients Diagnosed With Idiopathic Pulmonary Fibrosis (IPF)
Who this might be right for
Idiopathic Pulmonary Fibrosis
Boehringer Ingelheim 113